Poor hydroxylator phenotypes of debrisoquine and S‐mephenytoin are not over‐represented in a group of patients with Parkinson's disease [letter]

1. Gudjonsson, O.
2. Sanz, E.
3. Alvan, G.
4. Aquilonius, S.
5. Reviriego, J.